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Conclusion: LM-VH-TCFA are clustered in mid-body of the left main artery with
infrequent positive remodeling.
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Background: Optical coherence tomography (OCT) of a bioresorbable vascular
scaffold (BVS) produces a highly reflective signal outlining struts. This signal
interferes with the measurement of strut thickness, as the boundaries cannot be
accurately identified, and with the assessment of coverage, because the neointimal
backscattering convolutes that of the polymer, frequently making them
indistinguishable from one another. We hypothesize that Gaussian line spread functions
(LSFs) can facilitate identification of strut boundaries, improving the accuracy of strut
thickness measurements and coverage assessment.
Methods: 48 randomly selected BVS struts from 12 patients in the ABSORB Cohort
B clinical study and 4 Yucatan minipigs were analyzed at baseline and follow-up (6
months in humans, 28 days in pigs). Signal intensities from the raw OCT backscattering
were fit to Gaussian LSFs for each interface, from which peak intensity and full-width-
at-half-maximum (FWHM) were calculated.
Results: Neointimal coverage resulted in significantly different LSFs and higher
FWHM values relative to uncovered struts at baseline (p<0.0001). Abluminal polymer-
tissue interfaces were also significantly different between baseline and follow-up
(p=0.0004 in humans, p<0.0001 in pigs). Using the location of the half-max of the LSF
as the polymer-tissue boundary, the average strut thickness was 158 ± 11 μm at baseline
and 152 ± 20 μm at 6 months (p=0.886), not significantly different from nominal strut
thickness.
Conclusion: Fitting the raw OCT backscattering signal to a Gaussian LSF facilitates
identification of the interfaces between BVS polymer and lumen or tissue. Such
analysis enables more precise measurement of the strut thickness and an objective
assessment of coverage.
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Background: Intravascular ultrasound-derived echogenicity analyses have been used
to estimate the degradation of the ABSORB scaffold in the ABSORB trials. Coronary
arterial remodeling and baseline IVUS morphology of the scaffolded plaque may be
related to the subsequent degradation of the ABSORB scaffold. We sough to analyze
the changes in ultrasound characteristics of the ABSORB scaffold in relationship to
the baseline IVUS morphology and remodeling pattern of the plaque scaffolded.
Methods: The study population consisted of all patients with available echogenicity
analyses at baseline and 6 (n=28) or 12 (n=35) months follow-up. Coronary remodeling
was evaluated for the scaffolded segments by the serial assessment of changes in
atheroma and EEM areas and classified as positive (PR), incomplete (IR) or negative
(NR) remodeling. Baseline plaque morphology was visually assessed by IVUS in each
cross-sectional area as calcified, fibro-necrotic or fibro-cellular.
Results: At 6 months no changes in hyper-echogenicity were found between the
baseline IVUS plaque morphology and various patterns of remodeling. At 12 months,
plaques scaffolded with PR were associated with a larger reduction in hyper-
echogenicity (median [95%CI] -30.56%[-38.92 – -20.43]) compared with IR
(-19.40%[-25.57 – -5.01]) or NR (-1.18%[-17.25 – 7.03]; p=0.017). At 12 months, a
trend toward a greater reduction in hyper-echogenicity in calcified plaques compared
to the other types was evident (calcified plaques -20.48%[-30.32 – -10.65] vs. fibro-
necrotic plaques -14.54%[-23.12 – -5.97] vs. fibro-cellular plaques -8.61[-19.71 –
2.49], p=0.054).
Conclusion: At 12 months, baseline IVUS morphology and positive remodeling of
the plaque scaffolded appear to influence the reduction in ultrasound material
parameters of the ABSORB scaffold. The two years results will be available at the time
of the presentation.
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Background: Advanced imaging modalities provide various findings in unstable
plaque in the coronary arteries. Optical coherence tomography (OCT) evaluates thin-
cap fibroatheroma (TCFA); whereas biomarkers reflect pathological process of
cardiovascular disease (CVD), such as unstable plaque, plaque rupture and thrombus
formation in acute coronary syndrome. The association between unstable plaque and
biomarkers has not been elucidated in vivo. Here, this study aimed to evaluate the
correlation between biomarkers (interleukin-6, IL-6; matrix metalloproteinase-9,
MMP-9, high sensitive C-reactive protein, hs-CRP) and plaque morphology using OCT
and to investigate the usefulness of these biomarkers for early risk stratification.
Methods: This study included 46 CVD patients (26 ACS patients and 20 patients with
effort angina pectoris; EAP) who underwent percutaneous coronary intervention (PCI).
Blood samples were collected before PCI. Culprit lesions were identified using
electrocardiography, coronary angiography, cardiac scintigraphy and pressure wire.
OCT was performed before stent implantation for assessing fibrous cap thickness,
TCFA (plaque burden >2 quadrant, fibrous cap measurement <80μm), and the presence
/ absence of thrombus and plaque rupture.
Results: Hs-CRP was significantly higher in ACS patients than EAP patients
(0.313±0.094 vs. 0.073±0.011mg/dl, p=0.16). The patients with TCFA had significantly
higher hs-CRP (0.332±0.108mg/dl vs. 0.086±0.019mg/dl, p=0.16) and IL-6
(14.16±7.43pg/ml vs. 3.72±1.39pg/dl, p=0.47) than those without TCFA. Fibrous cap
thickness was significantly thinner (80.8±12.2μm vs.177.5±18.8μm, p<0.001) and
plaque rapture and thrombus were significantly greater in ACS patients than EAP
patients. Fibrous cap thickness correlated with hs-CRP (r =-0.37, p=0.037) but not
correlated with IL-6 (r=-0.175, p=0.39) or MMP-9 (r=-0.117, p=0.354). The receiver
operator characteristic (ROC) curves resulted that the specificities and sensitivities of
hs-CRP and IL-6 were 70% and 72% (cut off at 0.081mg/dl) and 70% and 73% (cut
off at 1.81pg/ml), respectively, suggesting that these biomarkers probably identify
TCFA.
Conclusion: Hs-CRP and IL-6 were predictors of unstable plaque assessed with OCT.
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Background: We assessed culprit lesions of infarct-related arteries (IRA) using Virtual
Histology Intravascular Ultrasound (VH-IVUS) in 112 pts with acute ST elevation
myocardial infarction (STEMI).
Methods: STEMI pts were divided into 2 groups: IRA with total occlusion (TOI, n=67)
and partial-occluded IRA(POI, n=45). TIMI thrombus grade was evaluated: Gr 0, no
angiographic thrombus; Gr 1, possible thrombus; Gr 2, definite thrombus with greatest
dimensions ≤1/2 the vessel diameter(VD); Gr 3, definite thrombus with greatest
dimension 1/2 to 2 VD; Gr 4, definite thrombus with the largest dimension ≥2 VD;
and Gr 5; total occlusion. VH-thin-capped fibroatheroma (VH-TCFAs) was defined as
necrotic core (NC) >10% of plaque area, plaque burden >40%, and NC in contact with
the lumen for ≥3 image slices. Positive remodeling was defined as lesion/reference
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external elastic membrane >1.05.
Results: All TOI showed TIMI thrombus grade 5; however, grade 1 was most frequent
in POI (Gr 0, n=5; Gr 1, n=17; Gr 2, n=12; Gr 3, n=9; Gr 4, n=2; and Gr 5, n=0). Vessel
size, lesion length, plaque burden, minimal lumen area (MLA), and remodeling index
were similar in TOI vs POI (Table). Plaque rupture was present in 48 pts: 27 TOI and
21 POI (p=0.3). Ruptured plaque cavity size was similar (0.81±0.78mm2 in TOI vs
0.93±0.81mm2 in POI, p=0.7). The incidence of VH-TCFAs tended to be higher in
TOIs [51% (34/67)] vs POI [27%(12/45), p=0.12]; %dense calcium within the culprit
lesions was larger in TOI vs POI (p=0.04); and peak troponin I was higher in TOI than
POI (366±218 mg/dl vs 156±260 mg/dl, p=0.012).
Conclusion: Totally-occluded IRAs in STEMI pts are associated with more culprit
lesion calcium and VH-TCFA morphology and greater myonecrosis indicating a higher
risk profile.
TCT-641
What Is the Optimal Blood Pressure for Coronary Plaque regression in
Hypertensive Patients? ALPS-J Sub-analysis
Akihisa Nishino1, Katsumi Miyauchi1, Takayuki Yokoyama1, Satoru Suwa2, Shinya
Okazaki3, Tadashi Miyazaki1, Takeshi Kurata1, Ken Yokoyama1, Hiroyuki Daida1
1Juntendo University, Tokyo, Japan; 2Juntendo University Shizuoka Hospital,
Shizuoka, Japan; 3Juntendo University Nerima Hospital, Tokyo, Japan
Background: Reduced blood pressure (BP) decreased the cardiovascular events as
well as coronary plaque in patients with hypertension. An inverse relationship between
diastolic pressure and adverse cardiac ischemic events has been observed in numerous
studies. However, the association between BP and coronary plaque regression remains
unclear. We hypothesized that BP reduction with CCB could be correlated with
coronary plaque of hypertensive patients after percutaneous coronary intervention as
post hoc analysis from ALPS-J.
Methods: ALPS-J was designed to evaluate the impact of CCB therapy on plaque
volume in hypertensive patient. Subjects were randomly assigned to receive 16mg/day
of azelnidipine or 5mg/day of amlodipine administered for 48 weeks. Changes in
atheroma burden during 10 months monitored by intravascular ultrasound were studied.
115 patients were completely assessed at baseline and 10-months IVUS data. The
percentage change in plaque volume showed a significant regression of -4.67 and -
4.85% in azelnidipine and amlodipine, respectively. In this sub-analysis, the
relationship between BP and coronary plaque volume was examined. Patients were
divided according to the four quantiles of level of systolic and diastolic BP, and
coronary plaque volume were assigned to 4 groups.
Results: There is no relationship between systolic or diastolic BP and plaque volume.
There was a 4% increase in the plaque volume when the diastolic BP was <70 mm Hg
compared with >70 mm Hg (5% decrease). A J shaped curve association existed
between BP and plaque volume, with lowest plaque regression in the BP range of
approximately 70 mm Hg diastolic.
Conclusion: This is the first study to demonstrate a J-shaped curve association existed
between BP and coronary plaque regression, with lowest coronary plaque volume in
the BP range of approximately 70mm Hg diastolic, which suggests that too low of a
pressure (especially less than70 mm Hg) may be dangerous.
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Background: Plaque composition and plaque growth are affected by multiple factors.
Among them, the role of endothelial wall shear stress(EWSS), however, on vulnerable
plaque growth is not well studied.
Methods: We evaluated coronary CT angiography and virtual histology intravascular
ultrasound(VH-IVUS) image data on left anterior descending artery(LAD) from six
patients with thin-cap fibroatheroma(TCFA) and 6 patients with non-TCFA. We
performed volumetric plaque analysis and investigated circumferential 360 degree of
EWSS in vessel wall by computational fluid dynamics.
Results: Pt’s characteristics are as follows: mean age 60.0±8.7 yrs, male 83%, diabetes
17%, unstable angina 92%. There were no significant differences between 2 groups in
vessel area, lumen area, plaque burden, and remodeling index. VH-IVUS showed that
absolute area of fibrofatty component was significant smaller, but absolute area and
relative amount of necrotic core(NC) components were significant larger in TCFA
group than non-TCFA group. Relative amount of NC increased as average
EWSS(r=0.752, p=0.008) and velocity increased(r=0.829, p=0.041) in MLA site.
Average EWSS, oscillatory shear index, and velocity values of proximal reference site,
minimal lumen area site, and distal reference site were not different between 2 groups.
Maximal EWSS, however, was significantly greater in TCFA group than non-TCFA
group(p=0.044)(Table).
Conclusion: EWSS may have influence on plaque growth, especially NC component.
Furthermore, high EWSS potentially contributes to plaque destabilization in advanced
plaques.
TCT-643
Six Month Follow Up Data of Orbital Atherectomy System for the Treatment of
De Novo Calcified Coronary Lesions (ORBIT I Trial)
Keyur Parikh1, Praveen Chandra2, Jeff Chambers3, Aruva Patel4
1Care Institue of Medical Sciences, Ahmedabad, India; 2Max Heart and Vascular
Institute, New Delhi, India; 3Mercy Hospital, Coon Rapids, MN;
4Smt.N.H.L.Municipal Medical College -V.S. Hospital, Ahmedabad, India
Background: Coronary Artery Disease continues to be a widespread and growing
problem worldwide. Performing PCI on calcified lesions can lead to MACE rates as
high as 24% at 30 days, stent malapposition and a number of procedural issues such
as perforation. The Orbit I trial evaluated the safety and performance of the
Diamondback 360 System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN) for the
treatment of de novo calcified coronary lesions.
Methods: The Orbit I study was a prospective, non randomized trial conducted at two
centers in India from May 2008 to July 2008. 50 non-consecutive patients with a de
novo, coronary lesion with stenosis ≥50% and ≤100% and at least one quadrant of
calcification via IVUS, were treated with the OAS prior to stent placement. The
endpoints were safety as measured by MACE rates, TLR, procedural success and
device performance at 6 months.
Results: Of the 50 patients, 90% were male and the average age was 57.4 years. The
ACC/AHA Lesion Class was: Type A 6.0%; Type B1 50.0%; Type B2 44.0%. The
lesion length was 13.4 mm, and the number of devices used per patient was 1.3. The
percent diameter stenosis was 85.6% pre OAS; 40.0% post-OAS. Procedural success
was 94% of patients achieving ≤20% residual stenosis post stent. Device success was
98%, with no device failures. The overall MACE rate was 4% in-hospital (2 non Q-
wave MI); 6% at 30 days (1 additional non Q-wave MI leading to TLR); 8% at 6
months (1 cardiac death). The angiographic complication rate was measured acutely
and resulted in 7 subjects with one event each (4 minor dissections; 1 major dissection;
2 perforations).
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